Status:
COMPLETED
Usability of Vibro-tactile Stimulation to Treat Spasmodic Dysphonia
Lead Sponsor:
University of Minnesota
Conditions:
Spasmodic Dysphonia
Laryngeal Dystonia
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
PHASE2
Brief Summary
The general aim of the study is to provide evidence for usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in peo...
Eligibility Criteria
Inclusion
- Diagnosis of spasmodic dysphonia (laryngeal dystonia) for a minimum of 6 months with documented symptom relief after Botox injection.
- Diagnosis is made by a voice disorder specialist.
Exclusion
- Regular intake of benzodiazepines
- Cognitive impairment: score \< 27 on Mini-mental state examination
- Identifies with a neurological or musculoskeletal impairment affecting speech motor function. These impairments may include a form of: Dyskinesia, Dystonia, Essential Tremor, Huntington's Disease, Multiple System Atrophy, Muscle Tension Dysphonia, Parkinsonism, Progressive Supranuclear Palsy, Spasticity, Intracranial Neoplasm (brain tumor), Spinal Neoplasm, Cerebrovascular Accident (Stroke), Mild Traumatic Brain Injury, Intracranial Hemorrhage, Multiple Sclerosis
Key Trial Info
Start Date :
September 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06111027
Start Date
September 20 2023
End Date
October 31 2024
Last Update
December 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55414